Accumulating evidence from recent studies have suggested that renal NLRP3 is activated in DKD animal models, while the inhibition of its activity could reduce the inflammation of renal tissues and improve renal functions (Wang et al., 2017; Chen K. et al., 2019; Han et al., 2019). Here, NLRP3 is linked to diabetic kidney disease.